Patchouli alcohol alleviates ulcerative colitis in mice by targeting PDI to reduce ER stress and inflammation
Background
Ulcerative colitis (UC) is a chronic inflammatory bowel disease (IBD) marked by mucosal damage and impaired epithelial barrier function. Current treatments often fall short, necessitating novel therapeutic strategies. Endoplasmic reticulum (ER) stress and inflammation are key drivers of UC pathology, contributing to intestinal epithelial injury. Natural compounds like Patchouli alcohol (PA) with known anti-inflammatory and antioxidant properties offer a promising avenue, but their precise mechanisms in UC, particularly regarding ER stress modulation, require further elucidation.
Study Design
Researchers investigated Patchouli alcohol (PA) in a dextran sulfate sodium (DSS)-induced ulcerative colitis mouse model to assess its therapeutic effects. They also used an LPS-induced inflammatory model in RAW264.7 cells to explore cellular mechanisms. Primary endpoints included assessment of UC symptoms, intestinal barrier integrity, inflammatory markers, and ER stress pathways. The study identified protein disulfide isomerase (PDI) as a direct target of PA and evaluated its impact on IRE1 activation.
Results
Patchouli alcohol (PA) significantly alleviated symptoms of DSS-induced ulcerative colitis in mice, demonstrating a clear therapeutic effect. This was accompanied by a reduction in intestinal barrier impairment and inhibition of inflammatory reactions. > In LPS-induced RAW264.7 cells, PA significantly downregulated the mRNA expression of il-1β and il-6, indicating its potent anti-inflammatory action at the cellular level. Mechanistically, protein disulfide isomerase (PDI) was identified as a direct molecular target of PA. By inhibiting IRE1 activation via PDI, PA effectively mitigated endoplasmic reticulum (ER) stress. This reduction in ER stress was crucial in preventing intestinal epithelial injury, thereby contributing to the overall alleviation of UC severity. The protective effect on the intestinal epithelial barrier was directly linked to PA's specific targeting of PDI and subsequent ER stress alleviation.
Key Findings
- Patchouli alcohol (PA) alleviated
DSS-induced ulcerative colitis symptoms in mice. - PA reduced intestinal barrier impairment and inhibited inflammatory reactions.
- PA downregulated
il-1βandil-6mRNA expression inLPS-inducedRAW264.7cells. Protein disulfide isomerase (PDI)was identified as a direct target of PA.- PA mitigated
ER stressand intestinal epithelial injury by inhibitingIRE1activation viaPDI.
Why It Matters
Patchouli alcohol (PA) emerges as a promising natural compound for ulcerative colitis (UC) treatment, offering a novel mechanism via ER stress modulation. This research provides a deeper understanding of PA's therapeutic potential, moving beyond its general anti-inflammatory properties to a specific molecular target: protein disulfide isomerase (PDI). For individuals seeking alternative or complementary strategies for UC, PA's ability to protect the intestinal barrier and reduce inflammation by mitigating ER stress is significant. While preclinical, these findings lay the groundwork for developing PA-based interventions, potentially as a standalone or adjunctive therapy, though human trials and specific dosing protocols are still distant.
patchouli alcohol
ulcerative colitis
er stress
inflammation
pdi
intestinal barrier